DARE   $3.7  2.78% Market Closed

Dare Bioscience Inc
Total Cash 16.41M
totalCashPerShare 1.921
EBITDA -26.70M
Total Debt 5.83M
quickRatio 1.187
currentRatio 1.428
Total Revenue 2.84M
debtToEquity 218.339
Revenue/Share 0.36
ROA -0.71422
ROE
grossProfits
freeCashflow -20.98M
operatingCashflow -10.06M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -327.99118
profitMargins -2.53602
enterpriseValue 19.16M
forwardPE -2.5588236
floatShares 8.41M
sharesOutstanding 8.55M
sharesShort 38.80K
sharesShortPriorMonth 39.24K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.07%
Short Ratio help_outline 1.60%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.313
Price To Book help_outline 11.12
earningsQuarterlyGrowth
netIncomeToCommon -7.20M
trailingEps 32.28%
forwardEps -1.36%
enterpriseToEbitda -0.72
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 3Q 2024
institutionsCount 29
lastUpdated Oct. 16, 2024, 12:25 p.m.